Company:  TAYSHA GENE THERAPIES, IN ... (TSHA)
Form Type:  S-1/A
Filing Date:  9/18/2020 
CIK:  0001806310 
Address:  7318 MORTON STREET 
City, State, Zip:  DALLAS, Texas 75209 
Telephone:  212.551.8702 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$20.02  
Change: 
-0.53 (-2.58%)  
Trade Time: 
Oct 23  
Market Cap: 
$716.96M
Trade TSHA now with 

© 2020  
Description of Business
BUSINESS Overview We are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. We were founded in partnership with The University of Texas Southwestern Medical Center, or UT Southwestern, to develop and commercialize transformative gene therapy treatments. Together with UT Southwestern, we are advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs at no cost.
Register and access this filing in:     
  FORM S-1/A
    TABLE OF CONTENTS
    PROSPECTUS SUMMARY
    The Offering
    SUMMARY FINANCIAL DATA
    RISK FACTORS
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    USE OF PROCEEDS
    DIVIDEND POLICY
    CAPITALIZATION
    DILUTION
      BENEFICIAL OWNERS
    SELECTED FINANCIAL DATA
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ...
      Operating Expenses
      Liquidity and Capital Resources
      Qualitative and Quantitative Disclosures About Market Risk
    BUSINESS
      Competition
      Employees
      Legal Proceedings
    MANAGEMENT
      NAME AND TITLE
      Compensation Committee Interlocks and Insider Participation
    Non-Employee Director Compensation
    EXECUTIVE COMPENSATION
      2020 Stock Incentive Plan
    CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
    PRINCIPAL STOCKHOLDERS
      BENEFICIAL OWNERS
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    SHARES ELIGIBLE FOR FUTURE SALE
    MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S ...
    UNDERWRITING
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
      Report of Independent Registered Public Accounting Firm
        BALANCE SHEET
        INCOME STATEMENT
        STOCKHOLDERS EQUITY
        CASH FLOW
      Notes to Financial Statements
    Note 1-Organization and Description of Business Operations
    Related Party Transactions
      STOCKHOLDERS EQUITY
    Note 1-Organization and Description of Business Operations
    PART II
      Item 13. Other Expenses of Issuance and Distribution.
      Item 14. Indemnification of Directors and Officers.
      Item 15. Recent Sales of Unregistered Securities.
      Item 16. Exhibits and Financial Statement Schedules.
      Item 17. Undertakings.
    SIGNATURES
  EXHIBIT 1.1
  EXHIBIT 23.1
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM